Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Evoke Pharma Announces 1-For-12 Reverse Stock Split Effective August 1, 2024

Author: Benzinga Newsdesk | July 30, 2024 08:31am

Common Stock To Trade On Split-Adjusted Basis Under Symbol EVOK With New CUSIP 30049G302

Posted In: EVOK